Walt Disney Co. shares fell sharply Thursday following its Q1 2026 earnings report, as investor focus shifted from beating profit expectations to uncertainty surrounding CEO Bob Iger's successor and cautious guidance on park attendance.
A partial government shutdown has forced the Bureau of Labor Statistics to postpone the critical January jobs report, leaving Federal Reserve policymakers without a key dataset as they weigh potential interest rate cuts ahead of their March meeting.
Amazon has filed a WARN notice indicating it will permanently eliminate 2,198 positions across multiple locations in Washington state by late April 2026, adding to a wave of corporate restructuring that has already seen thousands of layoffs in the region.
T-Mobile has filed a WARN notice with Washington state officials, signaling permanent layoffs for 393 employees across multiple locations starting April 2026, amid a broader wave of tech sector workforce reductions.
Newly filed state documents reveal the geographic breakdown of Amazon's latest workforce reduction in Washington, with T-Mobile and International Paper also submitting layoff notices affecting hundreds more employees across the state.
Amid a volatile market for mining stocks, Ramelius Resources stands out with a consistently high Return on Capital Employed (ROCE) of 30%, significantly outpacing its industry peers and fueling its multi-bagger potential.
Two Stanford graduate students have raised $2 million to launch Breakthrough Ventures, a nationwide accelerator designed to fund and mentor student-founded companies, addressing the historic lack of capital and networks for young entrepreneurs.
A severe, AI-driven shortage of memory chips is creating a windfall for storage manufacturers, with analysts predicting a multi-year upcycle as data center demand overwhelms supply.
While Broadcom rides a massive wave of AI demand, investor concerns over shrinking profitability have triggered a significant pullback in its shares, presenting a classic growth-versus-margin dilemma.
The data analytics firm smashed Wall Street forecasts for the fourth quarter, reporting a 70% revenue surge to $1.4 billion, driven by explosive growth in its U.S. operations. Its bullish outlook for 2025 further signals resilience amid sector-wide anxieties.
The Coast Guard has identified the seven individuals lost when the fishing vessel Lily Jean sank off the Massachusetts coast. As the community gathers to mourn, officials warn a complex investigation into the cause could take months.
A 25-year-old Johnstown woman faces 18 felony counts, including arson endangering lives, after investigators say she intentionally set a duplex fire that forced residents to leap from second-story windows to escape.
As AMD prepares to release its fourth-quarter results, the chipmaker finds itself at a critical juncture, balancing Wall Street's anxiety over AI infrastructure costs against its aggressive push to challenge Nvidia's dominance with new data center and PC products.
TD Cowen and H.C. Wainwright have raised price targets on KalVista Pharmaceuticals, expressing confidence in its oral hereditary angioedema treatment ahead of the company's fourth-quarter financial results.
Oppenheimer upgrades Relay Therapeutics (RLAY) to Outperform, citing the strength of its mutant-selective inhibitor pipeline and upcoming catalysts in the breast cancer treatment arena.
A deep dive into the software company's valuation using a discounted cash flow model suggests its shares may be trading at a significant premium to their estimated intrinsic value.
Despite recent sharp declines triggered by Fed nomination news, JPMorgan analysts reaffirm a bullish $6,300 per ounce gold target for 2026, citing resilient demand from central banks and investors.
Opera's stock surged following the announcement of expanded Tether (USDT and XAUT) integration in its MiniPay wallet, which processed over $153M in stablecoin transactions in December and aims to simplify crypto access for its 12.6 million users in emerging economies.
Clinical-stage biotech Erasca (ERAS) has seen its stock skyrocket over the past 12 months, hitting a multi-year high. While technical momentum is strong, the company remains pre-revenue, with its fate tied to future drug approvals, presenting a classic high-risk, high-reward scenario for investors.
As Palantir Technologies prepares to report Q4 results, soaring demand for its AI platform collides with sky-high valuations, leaving investors to weigh robust growth against bubble fears.
